Integra LifeSciences Boosts FY21 Outlook - Quick Facts

(RTTNews) - While reporting financial results for the second quarter on Wednesday, medical technology company Integra LifeSciences Holdings Corp. (IART) raised its adjusted earnings and revenue guidance for the full-year 2021, based on better than expected second quarter financial performance. The company also issued outlook for the third quarter.

For fiscal 2021, the company now projects adjusted earnings in a range of $2.98 to $3.05 per share on revenues between $1.540 billion and $1.550 billion, with revenue growth of 12 to 13 percent and organic revenue growth of 13 to 14 percent.

The company expected adjusted earnings in the range of $2.86 to $2.93 per share on revenues between $1.525 billion and $1.535 billion, with revenue growth of 11 to 12 percent and organic revenue growth of 12 to 13 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.92 per share on revenues of $1.53 billion for the year. Analysts' estimates typically exclude special items.

For the third quarter, the company expects adjusted earnings in a range of $0.71 to $0.74 per share on revenues between $382 million and $389 million, with revenue growth of 3 to 5 percent and organic revenue growth of 5 to 7 percent.

The Street is looking for earnings of $0.74 per share on revenues of $389.25 million for the quarter.